New Autism Therapy Restores Brain Signaling and Works in Adults: What August 2026’s Discovery Means
An August 7, 2026 study found blocking the SLC6A20 glycine transporter restored critical brain signaling and significantly improved social, communication, and repetitive behaviors in autism mouse models and human brain organoids β with effects even in adult mice. A 40-year pharmacist explains this breakthrough and what it means for autism treatment.
